Romano Deghenghi

Author PubWeight™ 21.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002 1.97
2 Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002 1.45
3 Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002 1.24
4 The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 2003 1.12
5 Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 2004 1.05
6 Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur J Pharmacol 2003 0.98
7 The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 2002 0.93
8 Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 2002 0.88
9 New active series of growth hormone secretagogues. J Med Chem 2003 0.87
10 Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. Endocrinology 2002 0.87
11 Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection. Neurosci Lett 2002 0.87
12 The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol (Oxf) 2002 0.85
13 Ghrelin: much more than a natural growth hormone secretagogue. Isr Med Assoc J 2002 0.83
14 PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release. Int J Pharm 2003 0.81
15 Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. J Clin Endocrinol Metab 2002 0.79
16 Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology 2003 0.79
17 Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency. Clin Endocrinol (Oxf) 2002 0.78
18 Ghrelin and synthetic GH secretagogues. Best Pract Res Clin Endocrinol Metab 2002 0.77
19 Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf) 2002 0.77
20 Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. Clin Endocrinol (Oxf) 2003 0.77
21 Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery. Eur J Pharmacol 2002 0.77
22 Ghrelin: endocrine and non-endocrine actions. J Pediatr Endocrinol Metab 2002 0.76
23 Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans. Eur J Endocrinol 2002 0.75
24 Growth hormone secretagogues: past, present and future. IDrugs 2002 0.75
25 Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6. Eur J Endocrinol 2002 0.75
26 Activation of GABAA and opioid receptors reduce penile erection induced by hexarelin peptides. Pharmacol Biochem Behav 2003 0.75
27 Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Neuroendocrinology 2002 0.75